Eledon pharmaceuticals ceo david-alexandre c. gros, m.d.

Presentation to focus on potential use of at-1501 in kidney transplantation as well as research collaboration between eledon and caredx to help assess the efficacy of eledon's investigational at-1501 for the prevention of rejection in upcoming kidney transplantation trials presentation to focus on potential use of at-1501 in kidney transplantation as well as research collaboration between eledon and caredx to help assess the efficacy of eledon's investigational at-1501 for the prevention of rejection in upcoming kidney transplantation trials
ELDN Ratings Summary
ELDN Quant Ranking